Archive for the ‘Pharmaceutical News’ Category

By Jennifer Ringler As the debate over the rising costs of new drug R&D and brand name medications rages on, physicians are increasingly doing their part to minimize collateral damage inflicted upon the patient. A new report from Bain & Company — The new cost-conscious doctor: changing America’s healthcare landscape — reveals that, increasingly, physicians [read more…]

By Bill Mears, CNN Supreme Court Producer Two women developed tardive dyskinesia after taking generic drugs The justices are considering cases against pharmaceutical manufacturers Generic drugs account for 70% of all prescriptions filled in the U.S. Washington (CNN) — Two women who say they suffered severe medical complications from a generic drug are asking the [read more…]

Medicinal products falling within the mandatory scope of the Annex of Regulation (EC) are obliged to apply for a Centralised Procedure: Recombinant DNA technology-Controlled expression of genes Hybridoma and monoclonal antibody methods Biosimilar biological medicinal products which are developed by one of the above Biotechnological processes also fall under the mandatory scope of the centralised [read more…]